The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine—A case report. Issue 4 (18th May 2020) - Kuzin, Maxim; Scharrer, Isabel; Nolan, Daniele; Baumgartner, Markus; Paulzen, Michael; Schoretsanitis, Georgios; Xepapadakos, Franziskos